Hudock Inc’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-50
Closed -$1K 317
2022
Q3
$1K Hold
50
﹤0.01% 711
2022
Q2
$1K Hold
50
﹤0.01% 702
2022
Q1
$3K Hold
50
﹤0.01% 657
2021
Q4
$3K Hold
50
﹤0.01% 662
2021
Q3
$4K Hold
50
﹤0.01% 674
2021
Q2
$6K Sell
50
-20
-29% -$2.39K ﹤0.01% 589
2021
Q1
$9K Hold
70
﹤0.01% 538
2020
Q4
$9K Buy
70
+20
+40% +$2.42K ﹤0.01% 525
2020
Q3
$5K Hold
50
﹤0.01% 532
2020
Q2
$4K Hold
50
﹤0.01% 533
2020
Q1
$2K Hold
50
﹤0.01% 555
2019
Q4
$4K Hold
50
﹤0.01% 516
2019
Q3
$4K Hold
50
﹤0.01% 524
2019
Q2
$5K Hold
50
﹤0.01% 495
2019
Q1
$4K Sell
50
-200
-80% -$17K ﹤0.01% 511
2018
Q4
$15K Hold
250
0.01% 339
2018
Q3
$19K Buy
250
+200
+400% +$13K 0.01% 356
2018
Q2
$2K Hold
50
﹤0.01% 589
2018
Q1
$2K Hold
50
﹤0.01% 589
2017
Q4
$2K Hold
50
﹤0.01% 571
2017
Q3
$2K Buy
+50
New +$2.01K ﹤0.01% 571

Other funds holding EXAS

Hudock Inc's EXAS Position: Q4 2022 in Review

Hudock Inc sold out of Exact Sciences (EXAS) in Q4 2022, closing a stake of 50 shares — an estimated $1K sold.

Hudock Inc first reported a position in EXAS in Q3 2017 and held it in 21 quarters. The position peaked at $19K in Q3 2018. 550 funds tracked by Wall St. Rank hold EXAS as of Q4 2022.

  • Hudock Inc reported no remaining Exact Sciences position as of Q4 2022 after selling out during the quarter.
  • Hudock Inc sold 50 Exact Sciences shares in Q4 2022, an estimated $1K.
  • Hudock Inc first reported a position in Exact Sciences in Q3 2017 and held it in 21 quarters.
  • Hudock Inc's Exact Sciences position peaked at $19K in Q3 2018.
  • 550 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2022.

Based on Hudock Inc's 13F filing for Q4 2022, filed 8 Feb 2023.